Accuray wins CyberKnife contract with Montecito Medical

Montecito Medical Ventures (MMV), a joint venture of Montecito Medical Investment Company, has formed an alliance by purchasing two placement contracts from Accuray, manufacturer of the CyberKnife radiosurgery system.

The purchase has created a program that gives healthcare providers that are affiliated with Montecito Medical access to medical technologies through its financing program. MMV will make a pool of investment capital for healthcare transactions available to providers interested in acquiring CyberKnife or other advanced medical technologies.

Using image guidance technology and computer controlled robotics, the CyberKnife System is designed to track the tumor, detect its location and make needed adjustments throughout the procedure, according to the Sunnyvale, Calif.-based Accuray.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.